Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Mesa Labs Inc (MLAB)

Mesa Labs Inc (MLAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Mesa Labs to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026 GlobeNewswire - Thu Dec 18, 6:00PM CST

LAKEWOOD, Colo., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB), a global leader in the design and manufacture of life science tools and critical quality control solutions, today...

MLAB : 80.67 (-0.43%)
Mesa Laboratories, Inc. to Announce Third Quarter Results on February 3, 2026 GlobeNewswire - Wed Dec 3, 4:35PM CST

LAKEWOOD, Colo., Dec. 03, 2025 (GLOBE NEWSWIRE) --  - Mesa Laboratories, Inc. (NASDAQ:MLAB) will issue a press release with financial results for the third quarter of fiscal year 2026 at approximately...

MLAB : 80.67 (-0.43%)
Mesa Laboratories, Inc. to Participate in Upcoming Investor Conferences GlobeNewswire - Wed Nov 12, 2:14PM CST

LAKEWOOD, Colo., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) today announced that Gary Owens, President and CEO, and John Sakys, CFO will be attending the following upcoming...

MLAB : 80.67 (-0.43%)
Mesa Labs: Fiscal Q2 Earnings Snapshot AP - Thu Nov 6, 6:01PM CST

Mesa Labs: Fiscal Q2 Earnings Snapshot

MLAB : 80.67 (-0.43%)
Mesa Labs Announces Second Quarter Results GlobeNewswire - Thu Nov 6, 3:15PM CST

LAKEWOOD, Colo., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (“Mesa” or “the Company”), a global leader in the design and manufacture of life science tools and critical...

MLAB : 80.67 (-0.43%)
MESA LABS DECLARES QUARTERLY DIVIDEND GlobeNewswire - Fri Oct 3, 10:01AM CDT

Lakewood, Colo., Oct. 03, 2025 (GLOBE NEWSWIRE) --  Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a regular...

MLAB : 80.67 (-0.43%)
AppLovin, Robinhood Markets and Emcor Group Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400 and S&P SmallCap 600 PR Newswire - Fri Sep 5, 5:34PM CDT

NEW YORK , Sept. 5, 2025 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 100, S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective...

APP : 727.50 (-0.13%)
ENPH : 32.85 (+1.96%)
WEN : 8.29 (+0.85%)
ACHC : 14.30 (+1.42%)
HL : 19.83 (-2.32%)
MKTX : 182.54 (-0.38%)
TTGT : 5.19 (-3.35%)
PUMP : 9.35 (-0.43%)
WAY : 33.01 (+0.52%)
SLP : 19.18 (-0.78%)
TRU : 86.71 (-0.13%)
SPGI : 525.74 (+0.11%)
Mesa Laboratories Executes Previously-Announced Strategic Financing Plan GlobeNewswire - Mon Aug 18, 1:01PM CDT

LAKEWOOD, Colo., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ: MLAB) (we, us, our, “Mesa” or the “Company”) today announced that it has executed on its previously-announced...

MLAB : 80.67 (-0.43%)
Mesa Labs: Fiscal Q1 Earnings Snapshot AP - Tue Aug 5, 7:10AM CDT

Mesa Labs: Fiscal Q1 Earnings Snapshot

MLAB : 80.67 (-0.43%)
Mesa Labs Announces First Quarter Results GlobeNewswire - Tue Aug 5, 7:00AM CDT

LAKEWOOD, Colo., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB), a global leader in the design and manufacture of life science tools and critical quality control solutions, today...

MLAB : 80.67 (-0.43%)

Barchart Exclusives

As the FDA Approves a Wegovy Pill, Should You Buy, Sell, or Hold Novo Nordisk Stock? Barchart - 13 minutes ago
As Novo Nordisk’s FDA-approved Wegovy pill sets up a high-stakes comeback, should NVO be back on investors’ radar now? Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot